85 related articles for article (PubMed ID: 15841297)
41. Curcumin-induced histone acetylation in malignant hematologic cells.
Hu J; Wang Y; Chen Y
J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):25-8. PubMed ID: 19224157
[TBL] [Abstract][Full Text] [Related]
42. The epigenetic modifier, valproic acid, enhances radiation sensitivity.
Karagiannis TC; Kn H; El-Osta A
Epigenetics; 2006; 1(3):131-7. PubMed ID: 17965607
[TBL] [Abstract][Full Text] [Related]
43. Trichostatin A promotes GLI1 degradation and P21 expression in multiple myeloma cells.
Geng Y; Liu J; Xie Y; Jiang H; Zuo K; Li T; Liu Z
Cancer Manag Res; 2018; 10():2905-2914. PubMed ID: 30214285
[TBL] [Abstract][Full Text] [Related]
44. Histone deacetylase inhibitors suppress IL-2-mediated gene expression prior to induction of apoptosis.
Koyama Y; Adachi M; Sekiya M; Takekawa M; Imai K
Blood; 2000 Aug; 96(4):1490-5. PubMed ID: 10942396
[TBL] [Abstract][Full Text] [Related]
45. Modulation of growth and differentiation of human colon carcinoma cells by histone deacetylase inhibitory trichostatins.
Li X; Yoshida M; Beppu T; Lotan R
Int J Oncol; 1996 Mar; 8(3):431-7. PubMed ID: 21544379
[TBL] [Abstract][Full Text] [Related]
46. Synergistic activity of the histone deacetylase inhibitor trichostatin A and the proteasome inhibitor PS-341 against taxane-resistant ovarian cancer cell lines.
Jin X; Fang Y; Hu Y; Chen J; Liu W; Chen G; Gong M; Wu P; Zhu T; Wang S; Zhou J; Wang H; Ma D; Li K
Oncol Lett; 2017 Jun; 13(6):4619-4626. PubMed ID: 28588720
[TBL] [Abstract][Full Text] [Related]
47. Trichostatin A enhances radiosensitivity and radiation-induced DNA damage of esophageal cancer cells.
Wang S; Song M; Zhang B
J Gastrointest Oncol; 2021 Oct; 12(5):1985-1995. PubMed ID: 34790366
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of Histone Methyltransferase, Histone Deacetylase, and
Yang J; Kaur K; Edwards JG; Eisenberg CA; Eisenberg LM
Stem Cells Int; 2017; 2017():3464953. PubMed ID: 28791052
[TBL] [Abstract][Full Text] [Related]
49. Histone deacetylase inhibitor trichostatin A enhances the antitumor effect of the oncolytic adenovirus H101 on esophageal squamous cell carcinoma
Ma J; Li N; Zhao J; Lu J; Ma Y; Zhu Q; Dong Z; Liu K; Ming L
Oncol Lett; 2017 Jun; 13(6):4868-4874. PubMed ID: 28599488
[TBL] [Abstract][Full Text] [Related]
50. Trichostatin A sensitizes hepatoma cells to Taxol more than 5-Aza-dC and dexamethasone.
Donia T; Khedr S; Salim EI; Hessien M
Drug Metab Pers Ther; 2021 Apr; ():. PubMed ID: 33818027
[TBL] [Abstract][Full Text] [Related]
51. Enhanced Cytotoxic Effects in Human Oral Squamous Cell Carcinoma Cells Treated with Combined Methyltransferase Inhibitors and Histone Deacetylase Inhibitors.
Ushio R; Hiroi M; Matsumoto A; Mori K; Yamamoto N; Ohmori Y
Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453513
[TBL] [Abstract][Full Text] [Related]
52. Accumulation of multiacetylated forms of histones by trichostatin A and its developmental consequences in early starfish embryos.
Ikegami S; Ooe Y; Shimizu T; Kasahara T; Tsuruta T; Kijima M; Yoshida M; Beppu T
Rouxs Arch Dev Biol; 1993 Feb; 202(3):144-151. PubMed ID: 28305991
[TBL] [Abstract][Full Text] [Related]
53. Ability of plasma-activated acetated Ringer's solution to induce A549 cell injury is enhanced by a pre-treatment with histone deacetylase inhibitors.
Adachi T; Matsuda Y; Ishii R; Kamiya T; Hara H
J Clin Biochem Nutr; 2020 Nov; 67(3):232-239. PubMed ID: 33293763
[TBL] [Abstract][Full Text] [Related]
54. Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus.
Hulin-Curtis SL; Davies JA; Jones R; Hudson E; Hanna L; Chester JD; Parker AL
Oncotarget; 2018 May; 9(41):26328-26341. PubMed ID: 29899862
[TBL] [Abstract][Full Text] [Related]
55. CTCF regulates positioning of the human cystic fibrosis gene in association with a histone deacetylase.
Muck J
Genom Data; 2014 Dec; 2():82-4. PubMed ID: 26484076
[TBL] [Abstract][Full Text] [Related]
56. Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma.
Lin WC; Hsu FS; Kuo KL; Liu SH; Shun CT; Shi CS; Chang HC; Tsai YC; Lin MC; Wu JT; Kuo Y; Chow PM; Liao SM; Yang SP; Hong JY; Huang KH
J Mol Med (Berl); 2019 Mar; 97(3):435-436. PubMed ID: 30741319
[TBL] [Abstract][Full Text] [Related]
57. Divalproex sodium: A potential therapy for scleroderma digital ulcers.
Urban JR; King B
JAAD Case Rep; 2015 Jan; 1(1):44-5. PubMed ID: 27051678
[No Abstract] [Full Text] [Related]
58. Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review.
Bouyahya A; El Omari N; Bakha M; Aanniz T; El Menyiy N; El Hachlafi N; El Baaboua A; El-Shazly M; Alshahrani MM; Al Awadh AA; Lee LH; Benali T; Mubarak MS
Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297347
[TBL] [Abstract][Full Text] [Related]
59. Nuclear softening expedites interstitial cell migration in fibrous networks and dense connective tissues.
Heo SJ; Song KH; Thakur S; Miller LM; Cao X; Peredo AP; Seiber BN; Qu F; Driscoll TP; Shenoy VB; Lakadamyali M; Burdick JA; Mauck RL
Sci Adv; 2020 Jun; 6(25):eaax5083. PubMed ID: 32596438
[TBL] [Abstract][Full Text] [Related]
60. Full small molecule conversion of human fibroblasts to neuroectodermal cells via a cocktail of Dorsomorphin and Trichostatin A.
Hosseini Farahabadi SS; Ghaedi K; Shoaraye-Nejati A; Nasr-Esfahani MH
Regen Ther; 2020 Dec; 15():44-52. PubMed ID: 33426201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
